Autres langues Crossject Deutsche Boerse AG

Actions

74C

FR0011716265

Marché Fermé - Deutsche Boerse AG Autres places de cotation 08:02:11 16/07/2024			Varia. 5j.	Varia. 1 janv.
1,826 ^EUR	+2,70%		+18,57%	-59,78%

10/07	Crossject obtient un financement public de 7 millions d'euros pour son nouveau produit d'épinéphrine	MT
10/07	Crossject : financement public sécurisé jusqu'en 2026	CF

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Crossject to attend H.C. Wainwright 26th Annual Global Investment Conference	15/07
Markets Powered by Alternating Current	10/07
Crossject Gets EUR7 Million Public Funding for New Epinephrine Product	10/07
Crossject : financement public sécurisé jusqu'en 2026	10/07
Borsa di Italia: Mercati collegati alla corrente alternata	10/07
Bolsa de Madrid: Mercados conectados a la corriente alterna	10/07
Crossject is awarded a 6.9 million euros financing from the French Government, as part of the France 2030 innovation plan, to accelerate the development of ZENEO® Epinephrine	10/07
Crossject Receives EUR 6.9 Million Public Funding from the French Government, as Part of the France 2030 Innovation Plan, to Accelerate the Development of ZENEO Epinephrine	10/07
Crossject elaborates on ZEPIZURE potential in light of landmark RAMPART study and its own, recently published, bioequivalence study	27/06
Crossject elaborates on ZEPIZURE® potential in light of landmark RAMPART study and its own, recently published, bioequivalence study	26/06
Crossject SA Announces the Appointment of Dan Chiche as Chief Medical Officer North America	13/06
Crossject appoints Dan Chiche, MD as Chief Medical Officer North America	12/06
Crossject appoints Dan Chiche, MD as Chief Medical Officer North America	12/06
Crossject : succès de l'augmentation de capital	05/06
CROSSJECT : Success of the capital increase	05/06
Borsa di Italia: I mercati rimangono piatti	05/06
Bolsa de Madrid: Los mercados se mantienen planos	05/06
Crossject Raises EUR8 Million via Rights Offering	05/06
Crossject announces highly successful closing of its €8 million rights offering	04/06
Crossject Société Anonyme announced that it has received ?7.999999 million in funding	04/06

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Crossject Deutsche Boerse AG

Actions

74C

FR0011716265

Autres langues

Filtres